The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.
Open accessAbstract
OBJECTIVES AND DESIGN: Hepatitis C virus (HCV) has been recognized as an emerging sexually transmitted infection (STI) among HIV-positive MSM. However, HIV-negative MSM at high risk for HIV might also be at increased risk for HCV. We studied the HCV prevalence in HIV-negative MSM who start preexposure prophylaxis (PrEP) in Amsterdam. Phylogenetic analysis was used to compare HCV strains obtained from HIV-negative and HIV-positive MSM. METHODS: At enrolment in the Amsterdam PrEP demonstration project, HIV-negative MSM were tested for the presence of HCV antibodies and HCV RNA. If positive for HCV RNA, an HCV NS5B gene fragment (709 bp) was sequenced and compared with HCV isolates from HIV-positive MSM (n = 223) and risk groups other than MSM (n = 153), using phylogenetic analysis. RESULTS: Of 375 HIV-negative MSM enrolled in Amsterdam PrEP, 18 (4.8%, 95% confidence interval 2.9-7.5%) of participants were anti-HCV and/or HCV RNA positive at enrolment; 15 of 18 (83%) had detectable HCV RNA. HCV genotyping showed genotype 1a (73%), 4d (20%), and 2b (7%). All HCV-positive MSM starting PrEP were part of MSM-specific HCV clusters containing MSM with and without HIV. CONCLUSION: HCV prevalence among HIV-negative MSM who started PrEP was higher than previously reported. All HIV-negative HCV-positive MSM were infected with HCV strains already circulating among HIV-positive MSM. The increasing overlap between sexual networks of HIV-positive and HIV-negative MSM might result in an expanding HCV-epidemic irrespective of HIV-status. Hence, routine HCV testing should be offered to MSM at high risk for HIV, especially for those enrolling in PrEP programs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C. L., Gall, J.-M. L., Cua, É., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,698
Smith, D. B., Bukh, J., KUIKEN, C. L., Muerhoff, A. S., Rice, C. M., Stapleton, J. T., & Peter Simmonds, K. (2013) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,352
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapía, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,229
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R. C., O’Reilly, K., Koechlin, F. M., Rodolph, M., Hodges-Mameletzis, I., & Grant, R. M. (2016) · AIDS · doi:10.1097/qad.0000000000001145 · Cited by 1,026
EASL Recommendations on Treatment of Hepatitis C 2016
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 982
Micallef, J., Kaldor, J. M., & Dore, G. J. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 875
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Grebely, J., Page, K. A., Sacks‐Davis, R., van der Loeff, M. F. S., Rice, T., Bruneau, J., Morris, M. D., Hajarizadeh, B., Amin, J., Cox, A. L., et al. (2013) · Hepatology · doi:10.1002/hep.26639 · Cited by 388
Self-citationLack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection
Mehandru, S., Poles, M. A., Tenner‐Racz, K., Jean-Pierre, P., Manuelli, V., Lopez, P., Shet, A., Low, A., Mohri, H., Boden, D., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030484 · Cited by 287
van de Laar, T. J. W., Matthews, G. V., Prins, M., & Danta, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833c11a5 · Cited by 252
Self-citationHagan, H., Jordan, A. E., Neurer, J., & Cleland, C. M. (2015) · AIDS · doi:10.1097/qad.0000000000000834 · Cited by 230
Martin, N. K., Vickerman, P. T., Dore, G. J., & Hickman, M. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000179 · Cited by 133
Sexually acquired hepatitis C virus infection: a review
Chan, D. P. C., Sun, H., Wong, H. T. H., Lee, S. S., & Hung, C. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.05.030 · Cited by 133
High-risk drug practices tighten grip on London gay scene
Kirby, T., & Thornber-Dunwell, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60032-x · Cited by 124
Vanhommerig, J. W., Lambers, F. A. E., Schinkel, J., Geskus, R. B., Arends, J. E., van de Laar, T. J. W., Lauw, F. N., Brinkman, K., Gras, L., Rijnders, B. J. A., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv115 · Cited by 104
Self-citationVizcaya, L. S., Kouyos, R. D., Zahnd, C., Wandeler, G., Battegay, M., Darling, K., Bernasconi, E., Calmy, A., Vernazza, P., Furrer, H., et al. (2016) · Hepatology · doi:10.1002/hep.28769 · Cited by 94
de Bruijne, J., Schinkel, J., Prins, M., Koekkoek, S. M., Aronson, S. J., van Ballegooijen, M., Reesink, H. W., Molenkamp, R., & van de Laar, T. J. W. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01146-09 · Cited by 84
Self-citationUrbanus, A. T., van de Laar, T. J. W., Geskus, R. B., Vanhommerig, J. W., van Rooijen, M. S., Schinkel, J., Heijman, T., Coutinho, R. A., & Prins, M. (2013) · AIDS · doi:10.1097/qad.0000000000000126 · Cited by 67
Self-citationRemis, R. S., Liu, J., Loutfy, M. R., Tharao, W. E., Rebbapragada, A., Huibner, S., Kesler, M. A., Halpenny, R., Grennan, T., Brunetta, J. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158090 · Cited by 64
The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis
Lamoury, F. M. J., Jacka, B. P., Bartlett, S. R., Bull, R. A., Wong, A., Amin, J., Schinkel, J., Poon, A. F. Y., Matthews, G. V., Grebely, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131437 · Cited by 58
Self-citationAcute hepatitis C infection in HIV ‐negative men who have sex with men
McFaul, K., Maghlaoui, A., Nzuruba, M., Farnworth, S. P., Foxton, M., Anderson, M., Nelson, M. R., & Devitt, E. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12366 · Cited by 55
Volk, J. E., Marcus, J. L., Phengrasamy, T., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ129 · Cited by 51
On behalf of the PROUD Study Group, Dolling, D. I., Desai, M., McOwan, A., Gilson, R., Clarke, A., Fisher, M., Schembri, G., Sullivan, A. K., Mackie, N., et al. (2016) · Trials · doi:10.1186/s13063-016-1286-4 · Cited by 51
Stabilizing Incidence of Hepatitis C Virus Infection Among Men Who Have Sex With Men in Amsterdam
Vanhommerig, J. W., Stolte, I. G., Lambers, F. A. E., Geskus, R. B., van de Laar, T. J. W., Bruisten, S. M., Schinkel, J., & Prins, M. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000208 · Cited by 45
Self-citationShedding of hepatitis C virus into the rectum of HIV-infected men who have sex with men.
Foster, A. L., Gaisa, M. M., Hijdra, R. M., Turner, S. S., Morey, T. J., Jacobson, K. B., & Fierer, D. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw740 · Cited by 43
Owen, G. J. (2008) · Culture Health & Sexuality · doi:10.1080/13691050802061673 · Cited by 41
Shedding of hepatitis C virus in semen of human immunodeficiency virus-infected men.
Turner, S. S., Gianella, S., Yip, M. J.-S., van Seggelen, W. O., Gillies, R. D., Foster, A. L., Barbati, Z. R., Smith, D. M., & Fierer, D. S. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw057 · Cited by 41
Laguio-Vila, M. R., Thompson, M. G., Reynolds, S. B., Spencer, S., Gaglani, M., Naleway, A. L., Ball, S. W., Bozeman, S., Baker, S. F., Martínez‐Sobrido, L., et al. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu115 · Cited by 40
Bradshaw, D., Lamoury, F. M. J., Catlett, B., Applegate, T. L., McAllister, J., Dore, G. J., Matthews, G. V., & Danta, M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu550 · Cited by 35
Thomas, X. V., Grady, B. P. X., van der Meer, J. T. M., Ho, C. K. Y., Vanhommerig, J. W., Rebers, S. P. H., de Jong, M. D., van der Valk, M., Prins, M., Molenkamp, R., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000838 · Cited by 21
Self-citationLimited spread of hepatitis C among HIV-negative men who have sex with men in Stockholm, Sweden
Blaxhult, A., Samuelson, A., Ask, R., & Hökeberg, I. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413515192 · Cited by 19
Chen, Y., Wiberg, K. J., Hsieh, Y., Bansal, A., Bolzan, P., Guy, J., Maina, E., Cox, A. L., & Thio, C. L. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw137 · Cited by 14
Newsum, A. M., Ho, C. K. Y., Lieveld, F. I., van de Laar, T. J. W., Koekkoek, S. M., Rebers, S. P. H., van der Meer, J. T. M., Wensing, A. M. J., Boland, G. J., Arends, J. E., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001263 · Cited by 13
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA · doi:10.1001/jama.2018.8431 · Cited by 698
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Cooke, G., Andrieux‐Meyer, I., Applegate, T. L., Atun, R. A., Burry, J., Cheinquer, H., Dusheiko, G. M., Feld, J. J., Gore, C., Griswold, M., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30270-x · Cited by 550
Spearman, C. W., Dusheiko, G. M., Hellard, M. E., & Sonderup, M. W. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32320-7 · Cited by 404
Bhattacharya, D., Aronsohn, A. I., Price, J. C., Re, V. L., Heald, J., Demisashi, G., Durzy, E., Davis-Owino, A., & Tynes, S. A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad319 · Cited by 345
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
Indolfi, G. (2018) · Florence Research (University of Florence) · Cited by 220
Chow, E. P. F., Grulich, A. E., & Fairley, C. K. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30043-8 · Cited by 176
Boerekamps, A., van den Berk, G. E. L., Lauw, F. N., Leyten, E. M. S., van Kasteren, M. E. E., van Eeden, A., Posthouwer, D., Claassen, M. A. A., Dofferhoff, A. S. M., Verhagen, D. W. M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1007 · Cited by 169
Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
Nguyen, V., Greenwald, Z. R., Trottier, H., Cadieux, M., Goyette, A., Beauchemin, M., Charest, L., Longpré, D., Lavoie, S., Tossa, H. G., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001718 · Cited by 167
Vuylsteke, B., Reyniers, T., Baetselier, I. D., Nöstlinger, C., Crucitti, T., Buyze, J., Kenyon, C. R., Wouters, K., & Laga, M. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25407 · Cited by 112
Nijmeijer, B. M., Koopsen, J., Schinkel, J., Prins, M., & Geijtenbeek, T. B. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25348 · Cited by 100
Self-citationHoornenborg, E., Achterbergh, R., van der Loeff, M. F. S., Davidovich, U., van der Helm, J. J., Hogewoning, A. A., van Duijnhoven, Y. T., Sonder, G. J. B., de Vries, H. J. C., Prins, M., et al. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25105 · Cited by 90
Self-citationManagement of acute HCV infection in the era of direct-acting antiviral therapy
Martinello, M., Hajarizadeh, B., Grebely, J., Dore, G. J., & Matthews, G. V. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0026-5 · Cited by 97
Reyniers, T., Nöstlinger, C., Laga, M., Baetselier, I. D., Crucitti, T., Wouters, K., Smekens, B., Buyze, J., & Vuylsteke, B. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001791 · Cited by 83
Popping, S., Bade, D., Boucher, C. A., van der Valk, M., El-Sayed, M. H., Sigurour, O., Sypsa, V., Morgan, T. R. M., Gamkrelidze, A., Mukabatsinda, C., et al. (2019) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30281-8 · Cited by 74
High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis
Hoornenborg, E., Coyer, L., Boyd, A. C., Achterbergh, R., van der Loeff, M. F. S., Bruisten, S. M., de Vries, H. J. C., Koopsen, J., van de Laar, T. J. W., Prins, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.022 · Cited by 72
Self-citationIngiliz, P., Wehmeyer, M. H., Boesecke, C., Wiesch, J. S. Z., Schewe, K., Lutz, T. A., Baumgarten, A., Simon, K., Hueppe, D., Rockstroh, J. K., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz949 · Cited by 68
Garvey, L. J., Cooke, G., Smith, C. J., Stingone, C., Ghosh, I., Dakshina, S., Jain, L., Waters, L. J., Mahungu, T. W., Ferro, F., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa021 · Cited by 67
Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men
Charre, C., Cotte, L., Kramer, R., Miailhes, P., Godinot, M., Koffi, J., Scholtès, C., & Ramière, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190340 · Cited by 65
Cotte, L., Cua, É., Reynes, J., Raffi, F., Rey, D., Delobel, P., Gagneux‐Brunon, A., Jacomet, C., Palich, R., Laroche, H., et al. (2018) · Liver International · doi:10.1111/liv.13922 · Cited by 64
2016 United Kingdom national guideline on the sexual health care of men who have sex with men
Clutterbuck, D., Asboe, D., Barber, T., Emerson, C., Field, N. M., Gibson, S., Hughes, G., Jones, R., Murchie, M., Nori, A., et al. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462417746897 · Cited by 67
Ramière, C., Charre, C., Miailhes, P., Bailly, F., Radenne, S., Uhrés, A.-C., Brochier, C., Godinot, M., Chiarello, P., Pradat, P., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz160 · Cited by 61
Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries
Hoornenborg, E., Krakower, D., Prins, M., & Mayer, K. H. (2017) · AIDS · doi:10.1097/qad.0000000000001627 · Cited by 61
Self-citationHosseini‐Hooshyar, S., Hajarizadeh, B., Bajis, S., Law, M. G., Janjua, N. Z., Fierer, D. S., Chromy, D., Rockstroh, J. K., Martin, T., Ingiliz, P., et al. (2021) · SSRN Electronic Journal · doi:10.1016/s2352-3018(22)00077-7 · Cited by 59
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
Patel, S. V., Jayaweera, D. T., Althoff, K. N., Eron, J. J., Radtchenko, J., Mills, A., Moyle, G. J., Santiago, S., Sax, P. E., Gillman, J. L., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228847 · Cited by 55
Linkage and retention in HCV care for HIV ‐infected populations: early data from the DAA era
Sacks‐Davis, R., Doyle, J., Rauch, A., Béguelin, C., Pedrana, A. E., Matthews, G. V., Prins, M., van der Valk, M., Klein, M. B., Saeed, S., et al. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25051 · Cited by 55
Self-citationKenyon, C. R., Wouters, K., Platteau, T., Buyze, J., & Florence, É. (2018) · AIDS Research and Therapy · doi:10.1186/s12981-018-0201-3 · Cited by 53
Koopsen, J., van Steenbergen, J., Richardus, J. H., Prins, M., de Coul, E. O., Croes, E. A., Heil, J., Zuure, F. R., & Veldhuijzen, I. K. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819000359 · Cited by 43
Self-citationMartin, N. K., Boerekamps, A., Hill, A. M., & Rijnders, B. J. A. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25062 · Cited by 43
Dried blood spot self-sampling at home is a feasible technique for hepatitis C RNA detection
Prinsenberg, T., Rebers, S. P. H., Boyd, A. C., Zuure, F. R., Prins, M., van der Valk, M., & Schinkel, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231385 · Cited by 42
Self-citationvan de Vijver, D. A. M. C., Richter, A.-K., Boucher, C. A., Gunsenheimer‐Bartmeyer, B., Kollan, C., Nichols, B. E., Spinner, C. D., Wasem, J., Schewe, K., & Neumann, A. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.7.1800398 · Cited by 41
Sexual risk behaviour trajectories among MSM at risk for HIV in Amsterdam, the Netherlands
Basten, M., Heijne, J. C. M., Geskus, R. B., den Daas, C., Kretzschmar, M., & Matser, A. A. (2018) · AIDS · doi:10.1097/qad.0000000000001803 · Cited by 38
Lockart, I., Matthews, G. V., & Danta, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000515 · Cited by 37
Coyer, L., van Bilsen, W., Bil, J. P., Davidovich, U., Hoornenborg, E., Prins, M., & Matser, A. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205663 · Cited by 35
Self-citationPopping, S., Hullegie, S. J., Boerekamps, A., Rijnders, B. J. A., de Knegt, R. J., Rockstroh, J. K., Verbon, A., Boucher, C. A., Nichols, B. E., & van de Vijver, D. A. M. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210179 · Cited by 37
Hepatitis and Global Infectious Diseases Consensus Panel European Treatment Network for HIV (2020) · AIDS · doi:10.1097/qad.0000000000002622 · Cited by 35
the Dat’AIDS Study Group, Virlogeux, V., Zoulim, F., Puglièse, P., Poizot‐Martin, I., Valantin, M., Cuzin, L., Reynes, J., Billaud, E., Huleux, T., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0979-1 · Cited by 35
Strategies for achieving viral hepatitis C micro-elimination in the Netherlands
Kracht, P. A. M., Arends, J. E., van Erpecum, K. J., Urbanus, A. T., Willemse, J. A., Hoepelman, A. I. M., & Croes, E. A. (2018) · Hepatology Medicine and Policy · doi:10.1186/s41124-018-0040-9 · Cited by 30
Price, J. C., McKinney, J. E., Crouch, P.-C., Dillon, S. M., Radix, A., Stivala, A., Carollo, J. R., & Fierer, D. S. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy670 · Cited by 29
van Aar, F., Kroone, M. M., de Vries, H. J. C., Götz, H. M., & BENTHEM, B. H. B. V. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.14.1900377 · Cited by 29
Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.
Gras, J., Mahjoub, N., Charreau, I., Cotte, L., Tremblay, C., Chas, J., Raffi, F., Cua, E., Guillon, B., Guigue, N., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002364 · Cited by 28
Cachay, E. R., Hill, L. A., Torriani, F. J., Ballard, C., Grelotti, D. J., Aquino, A., & Mathews, W. C. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy173 · Cited by 28
Transmission of hepatitis C virus in HIV‐positive and PrEP‐using MSM in England
Bradshaw, D., Vasylyeva, T. I., Davis, C., Pybus, O. G., Thézé, J., Thomson, E. C., Martinello, M., Matthews, G. V., Burholt, R., Gilleece, Y. C., et al. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13286 · Cited by 28
Jongen, V. W., Reyniers, T., Ypma, Z. M., van der Loeff, M. F. S., Davidovich, U., Zimmermann, H. M. L., Coyer, L., van den Elshout, M. A. M., de Vries, H. J. C., Wouters, K., et al. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25768 · Cited by 27
Self-citationTraeger, M. W., Harney, B. L., Sacks‐Davis, R., van Santen, D. K., Cornelisse, V. J., Wright, E., Hellard, M. E., Doyle, J., & Stoove, M. A. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad401 · Cited by 26
Chaillon, A., Sun, X., Cachay, E. R., Looney, D. J., Wyles, D. L., Garfein, R. S., Martin, T., Jain, S., Mehta, S. R., Smith, D. M., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz160 · Cited by 26
Eliminating viral hepatitis C in Belgium: the micro-elimination approach
Busschots, D., Toghanian, S., Bielen, R., Salomonsson, S., Koc, Ö. M., Hendrickx, G., Jadoul, M. Y., Nevens, F., Sokal, E. M., Brixko, C., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4898-y · Cited by 24
Current and future strategies for the treatment of chronic hepatitis C
Alshuwaykh, O. S., & Kwo, P. Y. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0230 · Cited by 24
The Elimination of Hepatitis C as a Public Health ThreatPreprint
Hellard, M. E., Schroeder, S., Pedrana, A. E., Doyle, J., & Aitken, C. K. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036939 · Cited by 23
Reed, J. B., Patel, R. R., & Baggaley, R. C. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418787896 · Cited by 18
Cuypers, L., Pérez, A. B., Chueca, N., Aldámiz‐Echevarría, T., Alados, J. C., Martínez-Sapiña, A. M., Merino, D., Pineda, J. A., Téllez, F., Espinosa, N., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201268 · Cited by 20
Braun, D. L., Hampel, B., Martin, E. M., Kouyos, R. D., Kusejko, K., Grube, C., Flepp, M., Stöckle, M., Conen, A., Béguelin, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy545 · Cited by 18
Grov, C., Westmoreland, D. A., Carrico, A. W., & Nash, D. (2020) · AIDS Care · doi:10.1080/09540121.2020.1739204 · Cited by 18
van den Elshout, M. A. M., Wijstma, E. S., Boyd, A. C., Jongen, V. W., Coyer, L., Anderson, P. L., Davidovich, U., de Vries, H. J. C., Prins, M., van der Loeff, M. F. S., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004328 · Cited by 17
Self-citationIs reaching 90–90–90 enough to end AIDS? Lessons from Amsterdam
de Bree, G. J., van Sighem, A., Zuilhof, W., van Bergen, J. E. A. M., Prins, M., Heidenrijk, M., van der Valk, M., Brokx, P., & Reiss, P. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000586 · Cited by 17
Self-citationSoriano, V., Benítez‐Gutiérrez, L., Arias, A. B. V., Carrasco, I., Barreiro, P., Peña, J. M., & de Mendoza, C. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1359254 · Cited by 17
Koopsen, J., Parker, E., Han, A. X., van de Laar, T. J. W., Russell, C. A., Hoornenborg, E., Prins, M., van der Valk, M., & Schinkel, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1830 · Cited by 15
Self-citationTabatabavakili, S., Aleyadeh, W., Cerocchi, O., Janssen, H. L. A., Hansen, B. E., Bogoch, I. I., & Feld, J. J. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.006 · Cited by 15
Bourlière, M., Pietri, O., Castellani, P., Oulès, V., & Adhoute, X. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818812358 · Cited by 15
Desai, M., White, E., Vora, N., Gilson, R. J. C., Lacey, C. J., Gafos, M., Clarke, A. E., Sullivan, A. K., White, D., Fox, J., et al. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13297 · Cited by 14
Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men
Rockstroh, J. K., & Boesecke, C. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa096 · Cited by 13
Steininger, L., Chromy, D., Bauer, D. J. M., Simbrunner, B., Binter, T., Schwabl, P., Schmidbauer, C., Trauner, M. A., Gschwantler, M., Mandorfer, M., et al. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01790-y · Cited by 13
Parczewski, M., Cielniak, I., Kordek, J., Aksak‐Wąs, B., Urbańska, A., Leszczyszyn‐Pynka, M., Siwak, E., Bociąga‐Jasik, M., Nowak, A., Szymczak, A., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001628 · Cited by 12
Nguyen, T., Delaugerre, C., Valantin, M., Amiel, C., Netzer, E., L’Yavanc, T., Ohayon, M., Valin, N., Day, N., Kreplak, G., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002099 · Cited by 12
study, O. B. O. T. M., Lambers, F. A. E., van der Veldt, W. M., Prins, M., & Davidovich, U. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3571-1 · Cited by 13
Self-citationVisseaux, B., Hué, S., Hingrat, Q. L., Salmona, M., Lebourgeois, S., Delaugerre, C., Descamps, D., Chaix, M., & Ghosn, J. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.034 · Cited by 12
Hepatitis C virus elimination: time for disruptive innovation
Klein, M. B. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25360 · Cited by 11
Thompson, K. A., Blank, G., Toy, J., Moore, D. M., Lachowsky, N. J., Bacani, N., Zhang, W., Sereda, P., Lima, V. D., Barrios, R., et al. (2022) · Liver International · doi:10.1111/liv.15237 · Cited by 11
Newsum, A. M., van Rooijen, M. S., Kroone, M. M., Bruisten, S. M., Matser, A. A., Hogewoning, A. A., Prins, M., & Heijman, T. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000877 · Cited by 10
Self-citationKoopsen, J., Matthews, G. V., Rockstroh, J. K., Applegate, T. L., Bhagani, S. R., Rauch, A., Grebely, J., Sacks‐Davis, R., Ingiliz, P., Boesecke, C., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00108-8 · Cited by 10
Self-citationCornelisse, V. J., Traeger, M. W., Wright, E., Murphy, D., Stoove, M. A., Hellard, M. E., Sacks‐Davis, R., Asselin, J., Fairley, C. K., Doyle, J., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002685 · Cited by 10
Inequities in atherosclerotic cardiovascular disease prevention
Gomez, S. E., Dudum, R., & Rodríguez, F. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.05.002 · Cited by 9
Care of Patients Following Cure of Hepatitis C Virus Infection.
Terrault, N. A. (2018) · Europe PMC (PubMed Central) · Cited by 9
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving
Popping, S., Nichols, B. E., Rijnders, B. J. A., van Kampen, J. J. A., Verbon, A., Boucher, C. A., & van de Vijver, D. A. M. C. (2019) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30031-5 · Cited by 10
Chen, P., Simonetto, D. A., Paul, S., & Patel, A. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000073 · Cited by 8
Nijmeijer, B. M., Eder, J., Langedijk, C. J. M., Kaptein, T. M., Meeussen, S., Zimmermann, P., Ribeiro, C. M. S., & Geijtenbeek, T. B. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00503 · Cited by 8
Todesco, E., Day, N., Amiel, C., Elaerts, S., Schneider, V., Roudière, L., Hué, S., Liotier, J.-Y., Bottero, J., L'Yavanc, T., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.02.002 · Cited by 7
Irvin, R., Gamble, T., Malone, J., Wang, Z., Wilson, E., Hughes, J. P., Farley, J. E., Mayer, K. H., del Rı́o, C., Batey, D. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1869 · Cited by 7
Murphy, D. G., Dion, R., Simard, M., Vachon, M.-L., Martel‐Laferrière, V., Serhir, B., & Longtin, J. (2019) · Canada Communicable Disease Report · doi:10.14745/ccdr.v45i09a02 · Cited by 7
Lampejo, T., Agarwal, K., & Carey, I. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.11.013 · Cited by 6
Hepatitis C infection among men who have sex with men living with HIV in New York City, 2000–2015
Gabai, C. M., Moore, M. S., Penrose, K., Braunstein, S., Bocour, A., Neaigus, A., & Winters, A. I. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054208 · Cited by 6
Brener, L., Murphy, D., Ellard, J., Cama, E. J., Fraser, N., & Murray, J. (2019) · Culture Health & Sexuality · doi:10.1080/13691058.2019.1615125 · Cited by 6
Current challenges in the clinical management of sexually transmitted infections
de Vries, H. J. C. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25347 · Cited by 6
Boender, T. S., de Coul, E. O., Arends, J. E., Prins, M., van der Valk, M., van der Meer, J. T. M., BENTHEM, B. H. B. V., Reiss, P., & Smit, C. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.7.1900450 · Cited by 6
Self-citationAmin, J., Vaccher, S. J., Templeton, D. J., Bavinton, B. R., Jin, F., Zablotska, I., Matthews, G. V., Ogilvie, E., Yeung, B., Ooi, C., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac231 · Cited by 6
Bartlett, S. R., Applegate, T. L., Jacka, B. P., Martinello, M., Lamoury, F. M. J., Danta, M., Bradshaw, D., Shaw, D., Lloyd, A. R., Hellard, M. E., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25222 · Cited by 6
Hill, L. A., Martin, N. K., Torriani, F. J., Jain, S., Qin, H., Mathews, W. C., & Cachay, E. R. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa643 · Cited by 6
Popping, S., Cuypers, L., Claassen, M. A. A., van den Berk, G. E. L., Weggheleire, A. D., Arends, J. E., Boerekamps, A., Molenkamp, R., Koopmans, M., Verbon, A., et al. (2022) · Viruses · doi:10.3390/v14091953 · Cited by 5
Popping, S., Haspels, S., Götz, H. M., van der Meijden, W. C. J. P. M., van den Elshout, M. A. M., & Rijnders, B. J. A. (2023) · Viruses · doi:10.3390/v15122317 · Cited by 5
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years
Graf, C., Fuhrmann, L., Lutz, T., Stephan, C., Knecht, G., Gute, P., Bickel, M., Peiffer, K., Finkelmeier, F., Dultz, G., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100701 · Cited by 6
Lions, C., Laroche, H., Zaegel‐Faucher, O., Ressiot, E., Brégigeon, S., de Lamarlière, P. G., Solas, C., Tamalet, C., Pieve, M.-A., Ritleng, A. S., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001640 · Cited by 5
Crowell, T. A., Qian, H., Tiemann, C., Lehmann, C., Boesecke, C., Stoehr, A. D., Hartikainen, J., Eßer, S., Bickel, M., Spinner, C. D., et al. (2021) · AIDS Research and Therapy · doi:10.1186/s12981-021-00378-4 · Cited by 5
Girometti, N., Devitt, E. J., Phillips, J., Nelson, M. R., & Whitlock, G. G. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13066 · Cited by 5
Bai, Z., Chen, Y., Chen, J., Pang, W., Zheng, R., Deng, M., Sun, R., Lan, Y., & Li, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1620371 · Cited by 4
Current and future challenges in HCV: insights from an Italian experts panel
Andreoni, M., Babudieri, S., Bruno, S., Colombo, M. G., Zignego, A. L., Marco, V. D., Perri, G. D., Perno, C. F., Puoti, M., Taliani, G., et al. (2017) · Infection · doi:10.1007/s15010-017-1093-1 · Cited by 4
Sacks‐Davis, R., Pedrana, A. E., Scott, N., Doyle, J., & Hellard, M. E. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1471355 · Cited by 4
Cuomo, G., Digaetano, M., Menozzi, M., Tagliazucchi, S., Guaraldi, G., Borghi, V., & Mussini, C. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.05.021 · Cited by 4
Ikeuchi, K., Okushin, K., Saito, M., Adachi, E., Tsutsumi, T., Takura, T., & Yotsuyanagi, H. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07152-5 · Cited by 4
Management of acute HCV in the era of direct-acting antivirals: implications for elimination
Martinello, M., & Matthews, G. V. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30001-9 · Cited by 3
Hage, K., Koole, J. C. D., Boyd, A. C., Matser, A. A., Davidovich, U., Bakker, M. E., van der Hoek, L., Koopsen, J., Rebers, S. P. H., Schinkel, J., et al. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003008 · Cited by 3
Self-citation
Metadata
- Authors
- Hoornenborg, E., Achterbergh, R. C. A., Schim van der Loeff, M. F., Davidovich, U., Hogewoning, A., de Vries, H. J. C., Schinkel, J., Prins, M., & van de Laar, T. J. W.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- GGD Amsterdam (NL)
- Corresponding author
- Prins, Maria
- Venue
- AIDS
- Published
- 2017-07-17
- Volume
- 31
- Issue
- 11
- Pages
- 1603-1610
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2611595043
- Cited by
- 137
- References
- 35
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 13 · 2022: 9 · 2021: 10 · 2020: 23 · 2019: 32 · 2018: 31 · 2017: 8
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Rivm (National Institute for Public Health and the Environment) (submittedVersion)
- Funders
- Gilead Sciences (CO‐NL‐276‐4222, PA-HIV-PREP-16-0024, CO-US-276-1712)
- ViiV Healthcare (3000747780, 3000268822)
- ZonMw (522002003)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- hepatitis C virus, men who have sex with men, pre-exposure prophylaxis, HIV-negative MSM, HCV prevalence, HCV genotyping, sexual networks, HCV screening
- MeSH terms
- Adult, Genotype, Hepatitis C, HIV Seropositivity, Humans, Longitudinal Studies, Male, Netherlands, Patient Acceptance of Health Care, Phylogeny, Prospective Studies, Risk Factors, Prevalence, Hepacivirus, HIV Seronegativity, Homosexuality, Male, Hepatitis C Antibodies, Unsafe Sex, Pre-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review